Top Markets
Coin of the day
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Rangering i aksjer #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Aksjekurs
$1.84
Sist synkronisert: 2026-08-11
Markedsverdi
$3.51M
Endring (1 dag)
0.46%
Endring (1 år)
-62.71%
Land
US
Handel Dogwood Therapeutics, Inc. (DWTX)

Kategori

Aksjeprishistorikk for Dogwood Therapeutics, Inc. (DWTX)
Høyeste sluttskurs: $1.81 den 2026-08-01

Laveste sluttskurs: $241.05 den 2020-12-01
Aksjeprishistorikk for Dogwood Therapeutics, Inc. fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -37.58%
2025 122.27%
2024 -84.09%
2023 144.93%
2022 -94.85%
2021 -47.68%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE